Novartis Vaccines and Diagnostics; Siena, Italy.
Gut Microbes. 2013 Sep-Oct;4(5):397-402. doi: 10.4161/gmic.25862. Epub 2013 Jul 25.
Clostridium difficile infection (CDI) is a major healthcare-associated disease worldwide. Recurring infections and increasing antibiotic resistance have complicated treatment of CDI. While C. difficile spores are important for transmission and persistence of CDI, other factors such as gut colonization and formation of bacterial communities in the gut may also contribute to pathogenesis and persistence, but have not been well investigated. Recently, we reported that important clinical C. difficile strains are able to form composite biofilms in vitro. C. difficile biofilm formation is a complex process, modulated by several different factors, including cell surface components and regulators. We also reported that bacteria within biofilms are more resistant to high concentrations of vancomycin, the antibiotic of choice for treatment of CDI. Here we summarize our recent findings and discuss the implications of biofilm formation by this anaerobic gut pathogen in disease pathogenesis and treatment.
艰难梭菌感染(CDI)是全球范围内主要的与医疗保健相关的疾病。反复发作的感染和不断增加的抗生素耐药性使 CDI 的治疗变得复杂。虽然艰难梭菌孢子对于 CDI 的传播和持续存在很重要,但其他因素,如肠道定植和肠道细菌群落的形成,也可能有助于发病机制和持续存在,但尚未得到充分研究。最近,我们报告说,重要的临床艰难梭菌菌株能够在体外形成复合生物膜。艰难梭菌生物膜的形成是一个复杂的过程,受多种不同因素的调节,包括细胞表面成分和调节剂。我们还报告说,生物膜内的细菌对万古霉素等治疗 CDI 的首选抗生素的高浓度更具耐药性。在这里,我们总结了我们最近的发现,并讨论了这种厌氧肠道病原体形成生物膜对疾病发病机制和治疗的影响。